Logo image of EVMT.CA

EVOME MEDICAL TECHNOLOGIES I (EVMT.CA) Stock Fundamental Analysis

Canada - TSX-V:EVMT - CA30053H1055 - Common Stock

0.005 CAD
0 (0%)
Last: 5/6/2025, 7:00:00 PM
Fundamental Rating

2

EVMT gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 15 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of EVMT have multiple concerns. EVMT is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

EVMT had negative earnings in the past year.
In the past year EVMT had a positive cash flow from operations.
EVMT had negative earnings in each of the past 5 years.
EVMT had negative operating cash flow in 4 of the past 5 years.
EVMT.CA Yearly Net Income VS EBIT VS OCF VS FCFEVMT.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 -5M -10M -15M -20M

1.2 Ratios

EVMT has a better Return On Assets (-66.99%) than 68.75% of its industry peers.
Industry RankSector Rank
ROA -66.99%
ROE N/A
ROIC N/A
ROA(3y)-20.97%
ROA(5y)-17.84%
ROE(3y)-154.4%
ROE(5y)-98.04%
ROIC(3y)N/A
ROIC(5y)N/A
EVMT.CA Yearly ROA, ROE, ROICEVMT.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 -100 -200 -300

1.3 Margins

Looking at the Gross Margin, with a value of 33.80%, EVMT is doing worse than 62.50% of the companies in the same industry.
EVMT's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for EVMT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 33.8%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-27.65%
GM growth 5YN/A
EVMT.CA Yearly Profit, Operating, Gross MarginsEVMT.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 -500 -1K -1.5K

More info and screens

2

2. Health

2.1 Basic Checks

EVMT does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, EVMT has more shares outstanding
Compared to 5 years ago, EVMT has more shares outstanding
The debt/assets ratio for EVMT is higher compared to a year ago.
EVMT.CA Yearly Shares OutstandingEVMT.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M
EVMT.CA Yearly Total Debt VS Total AssetsEVMT.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M

2.2 Solvency

Based on the Altman-Z score of -2.59, we must say that EVMT is in the distress zone and has some risk of bankruptcy.
EVMT has a Altman-Z score of -2.59. This is in the better half of the industry: EVMT outperforms 62.50% of its industry peers.
EVMT has a debt to FCF ratio of 3.25. This is a good value and a sign of high solvency as EVMT would need 3.25 years to pay back of all of its debts.
EVMT's Debt to FCF ratio of 3.25 is amongst the best of the industry. EVMT outperforms 100.00% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 3.25
Altman-Z -2.59
ROIC/WACCN/A
WACC8.49%
EVMT.CA Yearly LT Debt VS Equity VS FCFEVMT.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M 20M -20M

2.3 Liquidity

EVMT has a Current Ratio of 0.51. This is a bad value and indicates that EVMT is not financially healthy enough and could expect problems in meeting its short term obligations.
EVMT has a Current ratio of 0.51. This is in the lower half of the industry: EVMT underperforms 62.50% of its industry peers.
A Quick Ratio of 0.24 indicates that EVMT may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.24, EVMT is doing worse than 68.75% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.51
Quick Ratio 0.24
EVMT.CA Yearly Current Assets VS Current LiabilitesEVMT.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M

More info and screens

2

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 4.50% over the past year.
EVMT shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -39.95%.
EVMT shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 73.88% yearly.
EPS 1Y (TTM)4.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-140%
Revenue 1Y (TTM)-39.95%
Revenue growth 3Y438.98%
Revenue growth 5Y73.88%
Sales Q2Q%-49.05%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-400%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-0.65%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EVMT.CA Yearly Revenue VS EstimatesEVMT.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
EVMT.CA Yearly EPS VS EstimatesEVMT.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 -0.01 -0.02 -0.03 -0.04 -0.05

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for EVMT. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for EVMT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
EVMT.CA Price Earnings VS Forward Price EarningsEVMT.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, EVMT is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 0.06
EV/EBITDA N/A
EVMT.CA Per share dataEVMT.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 0.6 0.8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for EVMT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

EVOME MEDICAL TECHNOLOGIES I

TSX-V:EVMT (5/6/2025, 7:00:00 PM)

0.005

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)05-07 2025-05-07
Earnings (Next)08-11 2025-08-11
Inst Owners9.89%
Inst Owner ChangeN/A
Ins Owners0.19%
Ins Owner ChangeN/A
Market Cap300.85K
Revenue(TTM)48.34M
Net Income(TTM)-23.53M
Analysts80
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.01
P/FCF 0.06
P/OCF 0.06
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.29
EYN/A
EPS(NY)-0.05
Fwd EYN/A
FCF(TTM)0.09
FCFY1784.34%
OCF(TTM)0.09
OCFY1796.34%
SpS0.8
BVpS-0.06
TBVpS-0.19
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -66.99%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 33.8%
FCFM 11.1%
ROA(3y)-20.97%
ROA(5y)-17.84%
ROE(3y)-154.4%
ROE(5y)-98.04%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-27.65%
GM growth 5YN/A
F-Score3
Asset Turnover1.38
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 3.25
Debt/EBITDA N/A
Cap/Depr 1.09%
Cap/Sales 0.07%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.51
Quick Ratio 0.24
Altman-Z -2.59
F-Score3
WACC8.49%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)0.22%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)4.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-140%
EPS Next Y-400%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-39.95%
Revenue growth 3Y438.98%
Revenue growth 5Y73.88%
Sales Q2Q%-49.05%
Revenue Next Year-0.65%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y19.82%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year137.83%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y371.62%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y434.86%
OCF growth 3YN/A
OCF growth 5YN/A

EVOME MEDICAL TECHNOLOGIES I / EVMT.CA FAQ

What is the fundamental rating for EVMT stock?

ChartMill assigns a fundamental rating of 2 / 10 to EVMT.CA.


What is the valuation status for EVMT stock?

ChartMill assigns a valuation rating of 2 / 10 to EVOME MEDICAL TECHNOLOGIES I (EVMT.CA). This can be considered as Overvalued.


How profitable is EVOME MEDICAL TECHNOLOGIES I (EVMT.CA) stock?

EVOME MEDICAL TECHNOLOGIES I (EVMT.CA) has a profitability rating of 1 / 10.


What is the expected EPS growth for EVOME MEDICAL TECHNOLOGIES I (EVMT.CA) stock?

The Earnings per Share (EPS) of EVOME MEDICAL TECHNOLOGIES I (EVMT.CA) is expected to decline by -400% in the next year.